Fy13 priorities
Download
1 / 6

FY13 Priorities - PowerPoint PPT Presentation


  • 107 Views
  • Uploaded on

FY13 Priorities. Avant-Garde (DP1) A- START (R03/$100K) IAS /NIDA Fellowship ($75K) Advancing exceptional HIV /AIDS Research (R01/RFA) Technology-Base Adherence Research (PA) NIDA Drug Abuse and HIV Cohorts (PAR/U01) Provide supplements for NIAID’s ACTG

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' FY13 Priorities' - sue


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Fy13 priorities
FY13 Priorities

  • Avant-Garde (DP1)

  • A-START (R03/$100K)

  • IAS/NIDA Fellowship ($75K)

  • Advancing exceptional HIV/AIDS Research (R01/RFA)

  • Technology-Base Adherence Research (PA)

  • NIDA Drug Abuse and HIV Cohorts (PAR/U01)

  • Provide supplements for NIAID’s ACTG

  • OAR/NIDA/Russia and India Collaboration (R21)

  • Basic Biomedical (RFA/R01) (e.g., System Biology, Glia)

  • Novel Interventions PA (R34)

  • HIV, Drugs, & Vulnerable Pop PA (R21, R01)


Avant garde awardees fy 12
Avant-Garde Awardees FY 12

Jeremy Luban, M.D.

University of Massachusetts, Medical School, Worcester

David Smith, M.D.

University of California, San Diego School of Medicine

Samuel Friedman, Ph.D.

National Development and Research Institutes, New York City

Molecular epidemiology for HIV prevention for drug users and other risk groups

Preventing HIV transmission by recently-infected drug users

Human genes that influence HIV-1 replication, pathogenesis, and immunity in intravenous drug users


Aids science track award for research transition a start
AIDS-Science Track Award for Research Transition (A-START)

  • To facilitate the entry of new independent and early career investigators to the area of drug abuse research on HIV/AIDS

  • $100,000 per year, project duration of up to two years, non-domestic applicants are eligible


Recent international awards nida fellowship awardees
Recent International AwardsNIDA Fellowship Awardees

  • Abagiu, Adrian- Romania(2011)

  • Ahmed, Munir- Bangladesh(2009)

  • Boci, Arian- Albania(2008)

  • Chtenguelov, Victor- India(2005)

  • Desai, NimeshG.- India(2008)

  • Dvoriak, Sergii- Ukraine (2006)

  • Isralowitz, Richard- Israel (2005)

  • Kader, Rehana- South Africa (2008)

  • Kasirye, R.- Uganda(2003)

  • Khin, Thanda- Burma(2010)

  • Malta, Monica- Brazil(2005)

  • Nurhidayat, Adhi- Indonesia(2008)

  • Otiashvili, David- Georgia(2011)

  • Piralishvili, Gvantsa- Georgia(2009)

  • PoudyalChhetri, Meen- Nepal(2008)

  • Simoes, Anna- Brazil(2005)

  • Telles–Dias, Paulo Roberto- Brazil (2011)

  • Toussova, Olga- Russia(2007)

  • Tsarouk, Tatiana- Russia(2006)

  • Vasilev, Georgi- Bulgaria(2010)

  • Zhao, Min- China(2005)

  • Zubaran, Carlos- Australia(2010)


Topics u nder consideration
Topics Under Consideration

  • Cascade of Care Retention Gap

    • By Area, and risk group

  • Combination HIV Prevention Strategy

    • Implementation science approach

  • Alcohol, drug abuse, and HIV

    • Functional collaboration with NIAAA

  • Young minority MSM and prevention

  • Homeless/unstable housing

  • Integrating care: ID and addiction medicine



  • ad